Virtual Presentation

The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer

Source: Management of ER+ Postmenopausal Early Breast Cancer

The Role of Predictive Factors in Guiding Treatment Decisions for ER-Positive Postmenopausal Breast Cancer


Faculty:

  • William J. Gradishar, MD, FACP

CME CREDIT INFORMATION

Release Date: 04/28/08

Expiration Date: 04/27/09


Physicians: maximum of 0.5 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe how to optimize selection of endocrine treatments for breast cancer patients
  • Discuss patient characteristics, tumor characteristics, genetic profiles, estrogen receptor levels, and other markers and models to assess risk, and the need for chemotherapy in addition to hormonal therapy
  • Cite data comparing different prognostic signatures in making treatment choices for predicting benefit in breast cancer patients

CCO Virtual Presentations combine slides with audio commentary by our esteemed faculty. Complete the CME posttest and evaluation after watching the presentation.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.